Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

Yamanouchi prepares novel antimuscarinic agents for renal, GI and respiratory disorders

May 11, 1998

Wyeth-Ayerst has option to license Teikoku Hormone's antiandrogen

May 7, 1998

FDA clears CRYOcare surgical system to treat BPH

May 4, 1998

Cheung seeks FDA approval to begin testing of BPH treatment system

April 30, 1998

Takeda presents agents inhibiting PDGF activity for renal, cardiovascular disorders

April 29, 1998

New vasopressin V2 antagonists in development at Wakamoto

April 23, 1998

Synthelabo discloses new benzimidazoles for urinary incontinence

April 21, 1998

Alza acquires Canadian rights to Ditropan

April 20, 1998

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...